摘要
Abstract
Differed from the elderly patients with lung cancer,the younger patients with lung cancer,less than 50 years old,present unique clinical features.Recently,the incidence of lung cancer in young people has shown a rising trend,making the research on this field more valuable.At present,molecular targeted therapy is one of the most popular areas of non-small-cell lung cancer (NSCLC),and researches are focused on the epidermal growth factor receptor (EGFR) and echinoderm microtubule associated protein like4-anaplastic lymphoma kinase (EML4-ALK).In addition,the previous researches revealed the differences between the young and elderly patients with lung cancer on molecular genetics and prognosis,so the researches on prognostic factors for young patients with lung cancer are of great clinical significance.The present paper will focus on the aspects of pathogenesis,molecular genetics and prognosis in young patients with lung cancer.关键词
非小细胞肺癌/青年/年龄/分子遗传学/EML4-ALK融合,表皮生长因子受体/治疗/预后Key words
non-small cell lung cancer/young/age/molecular genetics/echinoderm microtubule associated protein like4-anaplastic lymphoma kinase/epidermal growth factor receptor/treatment/prognosis分类
医药卫生
